This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Alma Mater Studiorum-Universitá Di Bologna. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Biljana Petrovic: Innovator in Herpesvirus Research
Introduction
Biljana Petrovic is a notable inventor based in Bologna, Italy. She has made significant contributions to the field of virology, particularly in the development of recombinant herpesviruses. With a total of 2 patents, her work focuses on innovative therapeutic approaches to combat viral infections.
Latest Patents
One of her latest patents involves a recombinant herpesvirus that incorporates a heterologous polypeptide ligand capable of binding to a target molecule. This ligand is fused to or inserted into glycoprotein B at specific sites. The invention allows the herpesvirus to target cells for therapeutic purposes, as well as for virus production. Additionally, the patent includes a pharmaceutical composition that utilizes the herpesvirus for treating tumors, infections, degenerative disorders, or senescence-associated diseases. The invention also outlines methods for infecting cells with the herpesvirus and for producing the herpesvirus.
Career Highlights
Biljana Petrovic is affiliated with Alma Mater Studiorum - Università di Bologna, where she conducts her research and development work. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in therapeutic virology.
Collaborations
She collaborates with Maria Gabriella Campadelli, who is also a prominent figure in the field. Their partnership enhances the research efforts and broadens the scope of their innovative projects.
Conclusion
Biljana Petrovic's work in the field of herpesvirus research exemplifies the impact of innovation in medical science. Her patents and collaborations continue to pave the way for new therapeutic strategies against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile